Xenetic Biosciences, Inc. (XBIO)

NASDAQ: XBIO · Real-Time Price · USD

2.880

+0.220 (8.27%)

Aug 4, 2026, 10:45 AM EDT - Market open

Xenetic Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.35	7.88	6.17	8.98	13.1	18.24
Cash & Short-Term Investments	7.35	7.88	6.17	8.98	13.1	18.24
Cash Growth	42.29%	27.87%	-31.36%	-31.41%	-28.21%	58.27%
Other Current Assets	0.25	0.17	0.42	0.6	0.56	0.48
Total Current Assets	7.6	8.05	6.59	9.59	13.65	18.72
Other Long-Term Assets	0.31	0.31	0.31	1.02	1.07	1.09
Total Assets	7.91	8.36	6.9	10.61	14.72	19.82

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.56	0.26	0.28	0.24	0.29	0.36
Accrued Expenses	0.4	0.71	0.61	0.57	0.79	1.06
Total Current Liabilities	0.96	0.97	0.89	0.81	1.07	1.42
Total Liabilities	0.96	0.97	0.89	0.81	1.07	1.42

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Preferred Stock	0	0	0	0	0	0
Common Stock	0	0	0	0	0	0.01
Treasury Stock	-5.28	-5.28	-5.28	-5.28	-5.28	-5.28
Additional Paid-in Capital	212.31	212.29	208.23	208.05	207.77	205.95
Accumulated Other Comprehensive Income	0.25	0.25	0.25	0.25	0.25	0.25
Retained Earnings	-200.33	-199.88	-197.19	-193.23	-189.1	-182.55
Shareholders' Equity	6.95	7.4	6.01	9.8	13.65	18.39
Total Liabilities & Equity	7.91	8.36	6.9	10.61	14.72	19.82

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	7.35	7.88	6.17	8.98	13.1	18.24
Net Cash Growth	42.29%	27.87%	-31.36%	-31.41%	-28.21%	58.27%
Net Cash Per Share	3.89	4.63	4.00	5.88	9.21	17.75
Book Value	6.95	7.4	6.01	9.8	13.65	18.39
Book Value Per Share	3.68	4.35	3.90	6.41	9.59	17.89
Tangible Book Value	6.95	7.4	6.01	9.8	13.65	18.39
Tangible Book Value Per Share	3.68	4.35	3.90	6.41	9.59	17.89

SEC Filings: 10-K · 10-Q